1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(1-(vinylsulfonyl)piperidin-4-yl)urea

ID: ALA5279902

Chembl Id: CHEMBL5279902

Max Phase: Preclinical

Molecular Formula: C15H17ClF3N3O3S

Molecular Weight: 411.83

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CS(=O)(=O)N1CCC(NC(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)CC1

Standard InChI:  InChI=1S/C15H17ClF3N3O3S/c1-2-26(24,25)22-7-5-10(6-8-22)20-14(23)21-11-3-4-13(16)12(9-11)15(17,18)19/h2-4,9-10H,1,5-8H2,(H2,20,21,23)

Standard InChI Key:  IBAJEBJPTKAAOM-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5279902

    ---

Associated Targets(Human)

NCI-H358 (882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H23 (49055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 411.83Molecular Weight (Monoisotopic): 411.0631AlogP: 3.42#Rotatable Bonds: 4
Polar Surface Area: 78.51Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.33CX Basic pKa: CX LogP: 2.06CX LogD: 2.06
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.80Np Likeness Score: -1.98

References

1. Cheng R, Lv X, Bu H, Xu Q, Wu J, Xie K, Tang J, Wang L, Zhuang J, Zhang Y, Zhang Y, Yan C, Lai Y..  (2022)  Design, synthesis, and evaluation of 4(1H)-quinolinone and urea derivatives as KRASG12C inhibitors with potent antitumor activity against KRAS-mutant non-small cell lung cancer.,  244  [PMID:36228411] [10.1016/j.ejmech.2022.114808]

Source